A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on Telegram, where groups with numerous of members share comparison images, administration instructions and assertions of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Voice Worries
However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering substances of uncertain source.
Several professionals stated the demand for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.
Platform Response and Material Removal
According to the social media company, the service has taken down violative content and banned related keywords and query recommendations. The organization stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.
Digital Trading Operations
Research also found groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, positive testimonials and step-by-step instructions for preparing or administering at home.
Within moments of entering one group, a vendor posted contact information, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, health issues or previous experience.
Product Information and Pricing
Within these groups, posts display dark colored parcels with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering materials they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to potentially serious medical dangers”.
